
Compasionate Care for Your Unique Journey
The Dedicated Expert in Cancer Surgery in Central Florida
ABOUT me
ABOUT DR. SEBASTIAN DE LA FUENTE
Sebastian de la Fuente, MD, FACS, is a distinguished surgical oncologist with specialized training in the comprehensive management of pancreatic, liver, bile duct, gastric, and cutaneous malignancies. Possessing over a decade of dedicated experience in the field of oncological surgery, Dr. de la Fuente has established himself as a prominent figure within the medical community. Renowned for his expertise and commitment to patient care, he has earned distinction as one of the foremost practitioners in Florida, consistently delivering exceptional surgical outcomes and providing compassionate support to his patients and their families.
EDUCATION
General Surgery Residency: Duke University Medical Center, Durham, NC
​
Surgery Research Fellowship: Duke University Medical Center, Durham VAMC
​
Advanced Surgical Oncology Fellowship: Moffitt Cancer Center, University of South Florida, Tampa, FL
​
Board Certification:
-
American Board of Surgery
​
-
Society of Surgical Oncology: Advanced Surgical Oncology Certification
​
EXPERIENCE
Dr. Sebastian de la Fuente is deeply involved in multidisciplinary cancer care, recognizing the importance of collaboration among various medical specialties in providing comprehensive treatment to cancer patients. Through his expertise in surgical oncology, Dr. de la Fuente actively participates in interdisciplinary teams consisting of oncologists, radiologists, pathologists, and other healthcare professionals. Together, they formulate personalized treatment plans that integrate surgery with other modalities such as chemotherapy, radiation therapy, and immunotherapy, ensuring the best possible outcomes for patients across a spectrum of malignancies. He was instrumental in initiating the first program of Hepatic Artery Infusion for patients with liver metastases in Central Florida, and second in Florida.
RESEARCH
Comparison between transpapillary versus transmural endoscopic ultrasound-guided decompression for biliary obstruction: a meta-analysis. McCullers MR, Pinnola AD, de la Fuente SG.HPB (Oxford). 2023 Aug;25(8):855-862.
Benefits of EUS-guided gastroenterostomy over surgical gastrojejunostomy in the palliation of malignant gastric outlet obstruction: a large multicenter experience. Canakis A, Bomman S, Lee DU, Ross A, Larsen M, Krishnamoorthi R, Alseidi AA, Adam MA, Kouanda A, Sharaiha RZ, Mahadev S, Dawod S, Sampath K, Arain MA, Farooq A, Hasan MK, Kadkhodayan K, de la Fuente SG, Benias PC, Trindade AJ, Ma M, Gilman AJ, Fan GH, Baron TH, Irani SS.Gastrointest Endosc. 2023 Sep;98(3):348-359.
Clinical and Financial Implications of Consulting Physicians in the Management of Surgical Patients. Reza JA, Steve Eubanks W, de la Fuente SG.Am Surg. 2022 Apr;88(4):578-586.
Age as a prognostic indicator for adjuvant therapy in patients who underwent pancreatic resections for cancer. Eubanks A, Pepe J, Veldhuis P, de la Fuente SG.J Geriatr Oncol. 2018 Jul;9(4):362-366. doi: 10.1016/j.jgo.2017.12.004.
​
SERVICES

ONCOLOGIC PATIENT CARE
With extensive experience in the field of cancer care, Dr. Sebastian de la Fuente possesses a specialized focus on treating patients afflicted with cancers affecting the stomach, pancreas, liver, gallbladder, and skin. Additionally, he provides comprehensive care for individuals dealing with benign conditions related to the pancreas, liver, and bile duct systems.

INTERNATIONAL PATIENTS
Dr. de la Fuente offers consultation services for international patients seeking specialized care in oncology. With a wealth of experience in the field, he provides personalized assessments and treatment recommendations tailored to each patient's unique medical needs. International patients can expect compassionate and comprehensive care from Dr. de la Fuente and his team, ensuring a seamless experience throughout their journey towards improved health and well-being.

INDUSTRY CONSUTATIONS
Dr. Sebastian de la Fuente provides industry consultations in the fields of surgery and surgical oncology. Leveraging his expertise and experience, he offers valuable insights and strategic guidance to organizations, medical institutions, and professionals seeking to enhance their practices, refine surgical techniques, and optimize patient care protocols. Dr. de la Fuente's consultations are informed by cutting-edge research, clinical proficiency, and a commitment to advancing surgical excellence in the field of oncology.
01
CANCERS OF THE PANCREAS, LIVER AND BILIARY SYSTEM
Treatments for cancers of the pancreas, liver, and biliary system vary depending on factors like the stage of cancer, the patient's overall health, and specific characteristics of the tumor. Here are some common treatment modalities:
​
Surgery: Surgical options include:
-
Pancreaticoduodenectomy (Whipple procedure): This is often performed for pancreatic cancer that has not spread beyond the pancreas. It involves removing the head of the pancreas, part of the small intestine, the gallbladder, part of the stomach, and nearby lymph nodes.
-
Distal pancreatectomies: Removing part the left portion of the pancreas.
-
Liver resection: In cases of liver cancer, surgery may involve removing the tumor along with a portion of healthy liver tissue.
-
Biliary resection: Surgery to remove the affected portion of the bile duct may be performed for bile duct cancers.
​​
Chemotherapy: Chemotherapy drugs can be used to kill cancer cells or stop them from growing. It may be administered before surgery (neoadjuvant chemotherapy) to shrink the tumor, after surgery (adjuvant chemotherapy) to kill any remaining cancer cells, or as the primary treatment for advanced cases.
​
Radiation therapy: This treatment uses high-energy rays to kill cancer cells. It may be used alone or in combination with surgery and/or chemotherapy. Techniques like stereotactic body radiation therapy (SBRT) or intensity-modulated radiation therapy (IMRT) can be used to precisely target tumors while minimizing damage to surrounding healthy tissue.
​
Targeted therapy: This approach involves using drugs or other substances to specifically target cancer cells while minimizing damage to normal cells. Targeted therapies may include drugs that interfere with specific molecules involved in tumor growth and progression.
​
Immunotherapy: Immunotherapy drugs work by helping the body's immune system recognize and attack cancer cells. Immune checkpoint inhibitors, CAR-T cell therapy, and therapeutic cancer vaccines are among the immunotherapy approaches being studied for pancreatic, liver, and bile duct cancers.
​
Palliative care: In cases where the cancer is advanced and cannot be cured, palliative care focuses on providing relief from symptoms, improving quality of life, and offering support for both patients and their families. This may include pain management, nutritional support, and psychological support.
​​
Clinical trials: Participation in clinical trials can provide access to experimental treatments that may offer new hope for patients with pancreatic, liver, or biliary system cancers. These trials test new drugs, therapies, or treatment combinations to determine their safety and effectiveness.
​
It's important for patients to discuss their treatment options with a multidisciplinary team of healthcare providers, including surgeons, medical oncologists, radiation oncologists, and other specialists, to develop a personalized treatment plan tailored to their individual needs.
02
BENIGN CONDITIONS OF THE PANCREAS, LIVER AND BILE DUCTS
Treatment for benign conditions of the pancreas, liver, and bile ducts depends on the specific condition and its severity. Here are some common benign conditions and their treatment approaches:
Pancreatitis:
-
Acute Pancreatitis: Treatment often involves hospitalization, where patients receive intravenous fluids to prevent dehydration and may be kept nil by mouth to allow the pancreas to rest. Pain relief medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids, may be prescribed. In severe cases, patients may require nutritional support via a feeding tube. Identifying and addressing the underlying cause, such as gallstones or alcohol use, is also important.
-
Chronic Pancreatitis: Management focuses on pain relief, pancreatic enzyme replacement therapy to aid digestion, dietary modifications to avoid triggering factors, and lifestyle changes such as abstaining from alcohol and quitting smoking. In some cases, surgery may be necessary to alleviate blockages or remove damaged portions of the pancreas.
Liver Conditions:
-
Symptomatic liver cysts: Surgery is sometimes indicate to relieve symptoms related to large liver cysts.
Biliary Conditions:
-
Gallstones: Treatment of symptomatic patients (cholecystitis) involves surgical removal of the gallbladder (cholecystectomy) if symptoms are severe or complications arise.
-
Biliary Strictures: Treatment options include endoscopic procedures to widen narrowed bile ducts or surgery to remove or bypass the strictures.
03
SKIN CANCERS AND SARCOMAS
Cutaneous cancers, which include various types of skin cancers, are typically treated based on the type of cancer, its stage, location, and other individual factors. Here are some common treatment modalities for cutaneous cancers:
​
Surgery:
-
Excision: This involves surgically removing the cancerous lesion along with a margin of healthy tissue to ensure complete removal.
-
Wide local excision: For melanoma or other larger or deeper lesions, a wider margin of surrounding tissue may be removed to ensure complete removal of cancer cells.
-
Sentinel lymph node biopsy and lymphadenectomy: Removal of lymph nodes to determine the stage of the cancer.
​
Targeted therapy:
-
For advanced or metastatic melanoma, targeted therapy drugs may be used to block specific molecules involved in cancer growth, such as BRAF inhibitors or immune checkpoint inhibitors.​
Chemotherapy:
-
Systemic chemotherapy may be used for advanced or metastatic melanoma or other skin cancers that have spread beyond the skin. However, it's less commonly used for most cutaneous cancers due to limited effectiveness and significant side effects.
VERIFIED PATIENTS TESTIMONY
04/12/2024
"I have never had a more knowledgeable and concerned Doctor treating me in my life. Would recommend him to anyone"
04/12/2024
"Excellent doctor, Excellent practice."
04/05/2024
"Like I told Dr de la Fuente he was excellent and would recommend him to anybody but as you know it took me 2 years to get to his practice all I can say is keep up the good work thank you so much"
CONTACT US
If you have any questions or would like to schedule an appointment, please fill out the form below and we will get back to you as soon as possible.
PHONE
407-303-7399
ADDRESS
2415 N. Orange Ave, Suite 400
Orlando, FL 32804